Kim Olga, Yoon Jung Hwan, Choi Won Suk, Ashktorab Hassan, Smoot Duane T, Nam Suk Woo, Lee Jung Young, Park Won Sang
Department of Pathology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, 137-701, Korea.
Department of Medicine, Howard University, Washington, DC, 20060, USA.
Gastric Cancer. 2016 Apr;19(2):381-391. doi: 10.1007/s10120-015-0483-2. Epub 2015 Mar 10.
Gastrokine 1 (GKN1) acts as a gastric tumor suppressor. Here, we investigated whether GKN1 contributes to the maintenance of gastric mucosal homeostasis by regulating gastrin-induced gastric epithelial cell growth.
We assessed the effects of gastrin and GKN1 on cell proliferation in stable AGS(GKN1) and MKN1(GKN1) gastric cancer cell lines and HFE-145 nonneoplastic epithelial cells. Cell viability and proliferation were analyzed by MTT and BrdU incorporation assays, respectively. Cell cycle and expression of growth factor receptors were examined by flow cytometry and Western blot analyses.
Gastrin treatment stimulated a significant time-dependent increase in cell viability and proliferation in AGS(mock) and MKN1(mock), but not in HFE-145, AGS(GKN1), and MKN1(GKN1), cells, which stably expressed GKN1. Additionally, gastrin markedly increased the S-phase cell population, whereas GKN1 significantly inhibited the effect of gastrin by regulating the expression of G1/S cell-cycle regulators. Furthermore, gastrin induced activation of the NF-kB and β-catenin signaling pathways and increased the expression of CCKBR, EGFR, and c-Met in AGS and MKN1 cells. However, GKN1 completely suppressed these effects of gastrin via downregulation of gastrin/CCKBR/growth factor receptor expression. Moreover, GKN1 reduced gastrin and CCKBR mRNA expression in AGS and MKN1 cells, and there was an inverse correlation between GKN1 and gastrin, as well as between GKN1 and CCKBR mRNA expression in noncancerous gastric mucosae.
These data suggest that GKN1 may contribute to the maintenance of gastric epithelial homeostasis and inhibit gastric carcinogenesis by downregulating the gastrin-CCKBR signaling pathway.
胃动素1(GKN1)作为一种胃肿瘤抑制因子。在此,我们研究了GKN1是否通过调节胃泌素诱导的胃上皮细胞生长来维持胃黏膜稳态。
我们评估了胃泌素和GKN1对稳定表达GKN1的AGS(GKN1)和MKN1(GKN1)胃癌细胞系以及HFE - 145非肿瘤性上皮细胞增殖的影响。分别通过MTT法和BrdU掺入法分析细胞活力和增殖情况。通过流式细胞术和蛋白质印迹分析检测细胞周期和生长因子受体的表达。
胃泌素处理可显著刺激AGS(mock)和MKN1(mock)细胞的细胞活力和增殖随时间增加,但对稳定表达GKN1的HFE - 145、AGS(GKN1)和MKN1(GKN1)细胞无此作用。此外,胃泌素显著增加S期细胞群体,而GKN1通过调节G1/S细胞周期调节因子的表达显著抑制胃泌素的作用。此外,胃泌素诱导AGS和MKN1细胞中NF - kB和β - 连环蛋白信号通路的激活,并增加CCKBR、EGFR和c - Met的表达。然而,GKN1通过下调胃泌素/CCKBR/生长因子受体的表达完全抑制了胃泌素的这些作用。此外,GKN1降低了AGS和MKN1细胞中胃泌素和CCKBR mRNA的表达,在非癌性胃黏膜中,GKN1与胃泌素以及GKN1与CCKBR mRNA表达之间呈负相关。
这些数据表明,GKN1可能通过下调胃泌素 - CCKBR信号通路有助于维持胃上皮稳态并抑制胃癌发生。